A prospective, randomized controlled trial of conscious sedation using propofol combined with inhaled nitrous oxide for dental treatment
- PMID: 25530275
- DOI: 10.1016/j.joms.2014.09.014
A prospective, randomized controlled trial of conscious sedation using propofol combined with inhaled nitrous oxide for dental treatment
Abstract
Purpose: Adverse reactions during propofol sedation include a decrease in arterial blood pressure, propofol-induced pain on injection, and airway complications. The purpose of this study was to investigate whether combined use of intravenous propofol and inhaled nitrous oxide could decrease the hypotensive and other adverse effects of propofol.
Patients and methods: We designed and implemented a prospective, randomized controlled trial. Patients undergoing dental procedures requiring intravenous sedation were randomly allocated to 2 groups: group P comprised those receiving sedation with propofol alone, and group N+P comprised those receiving sedation with 40% nitrous oxide inhalation and propofol. During the dental procedures, the sedation level was maintained at an Observer's Assessment of Alertness/Sedation scale score of 4 by adjusting propofol's target plasma concentration. Nitrous oxide inhalation was the predictor variable, whereas the hemodynamic changes, amount and concentration of propofol, and adverse events were the outcome variables.
Results: Eighty-eight patients were successfully analyzed without any complications. The total amount of propofol was significantly less in group N+P (249.8 ± 121.7 mg) than in group P (310.3 ± 122.4 mg) (P = .022), and the mean concentration of propofol was significantly less in group N+P (1.81 ± 0.34 μg/mL) than in group P (2.05 ± 0.44 μg/mL) (P = .006). The mean blood pressure reduction in group N+P (11.0 ± 8.0 mm Hg) was significantly smaller than that in group P (15.8 ± 10.2 mm Hg) (P = .034). Pain associated with the propofol injection and memory of the procedure were less in group N+P (P = .011 and P = .048, respectively). Nitrous oxide did not affect respiratory conditions or recovery characteristics.
Conclusions: The results of this study suggest that nitrous oxide inhalation combined with propofol sedation attenuates the hypotensive effect and pain associated with propofol injections, along with potentiating the amnesic effect.
Copyright © 2015 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Improved sedation for oral surgery by combining nitrous oxide and intravenous Midazolam: a randomized, controlled trial.Int J Oral Maxillofac Surg. 2006 Jun;35(6):522-7. doi: 10.1016/j.ijom.2005.11.003. Epub 2006 Jan 25. Int J Oral Maxillofac Surg. 2006. PMID: 16442264 Clinical Trial.
-
The effect of nitrous oxide inhalation on the hypotensive response to propofol: a randomized controlled trial.Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Aug;118(2):166-73. doi: 10.1016/j.oooo.2013.03.020. Epub 2013 Jun 4. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014. PMID: 23743209 Clinical Trial.
-
A report on dental anxiety levels in children undergoing nitrous oxide inhalation sedation and propofol target controlled infusion intravenous sedation.Eur Arch Paediatr Dent. 2007 Jun;8(2):82-6. Eur Arch Paediatr Dent. 2007. PMID: 17555689
-
Nitrous oxide and the inhalation anesthetics.Anesth Prog. 2008 Winter;55(4):124-30; quiz 131-2. doi: 10.2344/0003-3006-55.4.124. Anesth Prog. 2008. PMID: 19108597 Free PMC article. Review.
-
Inhalation sedation with nitrous oxide: a review.Dent Update. 2000 Apr;27(3):141-2, 144, 146. doi: 10.12968/denu.2000.27.3.141. Dent Update. 2000. PMID: 11218285 Review.
Cited by
-
A fixed inhaled nitrous oxide/oxygen mixture as an analgesic for adult cancer patients with breakthrough pain: study protocol for a randomized controlled trial.Trials. 2017 Jan 11;18(1):13. doi: 10.1186/s13063-016-1739-9. Trials. 2017. PMID: 28077162 Free PMC article. Clinical Trial.
-
A fixed nitrous oxide/oxygen mixture as an analgesic for patients with postherpetic neuralgia: study protocol for a randomized controlled trial.Trials. 2021 Jan 6;22(1):29. doi: 10.1186/s13063-020-04960-5. Trials. 2021. PMID: 33407845 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources